BackAccuray Overview

Accuray Long Term Debt

Track Accuray's long-term debt ($58M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$57.98M
70.95% YoYΔ $-141.58M vs prior year quarter

Peer trimmed avg / median

Loading

Accuray Long Term Debt History

Loading

Accuray vs. peers: Long Term Debt Comparison

Loading

Accuray Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Accuray (ARAY) FAQ

As of the most recent data (March 2026), ARAY shows a long-term debt of $58M. That compares with $200M in the prior-year period — down 70.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARAY's long-term debt is now $58M (was $200M) — a 70.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Accuray is outperforming or lagging.

Tracking ARAY's long-term debt over time shows whether Accuray is scaling, shrinking, or reshaping that part of the business. The current reading is $58M That compares with $200M in the prior-year period — down 70.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Accuray's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $58M) with ownership activity and broader fundamentals.

Accuray's long-term debt is $58M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.